26.03 USD
▲-0.92+0.35%
盘后 25.94 0.00%
2026-08-03
市值
$3.26B
市盈率
—
EPS
-0.02
股息率
—
52 周区间
13.70 – 31.77
成交量
1.94M
Beta
1.48
目标价
34.63
52W 低 13.7052W 高 31.77
价格走势
公司简介
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company’s lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Bio...